1. Spallone A, Schwartz IS. Emerging Fungal Infections. Infect Dis Clin North Am. 2021;35:261-277.
2. Dukik K, Muñoz JF, Jiang Y et al. Novel taxa of thermally dimorphic systemic pathogens in the Ajellomycetaceae (Onygenales). Mycoses. 2017;60(5):296-309.
3. Schwartz IS, Kenyon C, Feng P et al. 50 Years of Emmonsia Disease in Humans: The Dramatic Emergence of a Cluster of Novel Fungal Pathogens. PLoS Pathog. 2015;11:e1005198.
4. Kenyon C, Bonorchis K, Corcoran C et al. A dimorphic fungus causing disseminated infection in South Africa. N Engl J Med. 2013;369(15):1416-24.
5. Hoving JC. Emergomyces africanus poses an emerging threat. Nat Microbiol. 2024;9:4-5.
6. Wellinghausen N, Kern WV, Haase G et al. Chronic granulomatous lung infection caused by the dimorphic fungus Emmonsia sp. Int J Med Microbiol. 2003;293:441–5.
7. Wang P, Kenyon C, de Hoog S et al. A novel dimorphic pathogen, Emergomyces orientalis (Onygenales), agent of disseminated infection. Mycoses. 2017;60:310-319.
8. Schwartz I.S, Maphanga T.G, Govender N.P. Emergomyces: a New Genus of Dimorphic Fungal Pathogens Causing Disseminated Disease among Immunocompromised Persons Globally. Curr
Fungal Infect Rep. 2018; 12, 44–50.
9. Schwartz IS, Sanche S, Wiederhold NP, Patterson TF, Sigler L. Emergomyces canadensis, a Dimorphic Fungus Causing Fatal Systemic Human Disease in North America. Emerg Infect Dis.
2018;24:758-761.
10. https://www.speciesfungorum.org/Names/Names.asp
11. Reddy DL, Nel J, Govender NP. Review: Emergomycosis. J Mycol Med. 2023;33:101313.
12. Er H. Emergomikoz. In: Tümbay E, ed. Tıbbi Mikoloji. 1. Baskı. İzmir: Meta Basım; 2021.
13. Bongomin F, Ekeng BE, Kibone W et al. Invasive Fungal Diseases in Africa: A Critical Literature Review. J Fungi (Basel). 2022;8:1236.
14. Schwartz IS, Govender NP, Sigler L et al. Emergomyces: The global rise of new dimorphic fungal pathogens. PLoS Pathog. 2019; 15: e1007977.
15. Thompson GR 3rd, Le T, Chindamporn A et al. Global guideline for the diagnosis and management of the endemic mycoses: an initiative of the European Confederation of Medical Mycology
in cooperation with the International Society for Human and Animal Mycology. Lancet Infect Dis. 2021;21:e364-e374.
16. Ibe C, Mnyambwa NP, Mfinanga SG. Emergomycosis in Africa: Time to Pay Attention to This Emerging Deadly Fungal Infection. Int J Gen Med. 2023;16:2313-2322.
17. Almeida-Paes R, Bernardes-Engemann AR, da Silva Motta B et al. Immunologic Diagnosis of Endemic Mycoses. J Fungi (Basel). 2022;8:993.
18. Maphanga TG, Britz E, Zulu TG et al. In Vitro Antifungal Susceptibility of Yeast and Mold Phases of Isolates of Dimorphic Fungal Pathogen Emergomyces africanus (Formerly Emmonsia sp.)
from HIV-Infected South African Patients. J Clin Microbiol. 2017;55:1812-1820.
TALAROMYCES MARNEFFEI
KAYNAKLAR
1. Bourassa L, Doppalapudi A, Butler-Wu SM. The Brief Case: Pneumonia Caused by Talaromyces marneffei. J Clin Microbiol. 2019; 57:e01690-18.
2. Wang F, Han R, Chen S. An Overlooked and Underrated Endemic Mycosis-Talaromycosis and the Pathogenic Fungus Talaromyces marneffei. Clin Microbiol Rev. 2023;36:e0005122.
3. Capponi M, Segretain G, Sureau P. Pénicillose de Rhizomys sinensis [Penicillosis from Rhizomys sinensis]. Bull Soc Pathol Exot Filiales. 1956;49:418-21.
4. Chan JF, Lau SK, Yuen KY, Woo PC. Talaromyces (Penicillium) marneffei infection in non-HIV-infected patients. Emerg Microbes Infect. 2016;5:e19.
5. Vanittanakom N, Cooper CR Jr, Fisher MC, Sirisanthana T. Penicillium marneffei infection and recent advances in the epidemiology and molecular biology aspects. Clin Microbiol Rev. 2006:
95-110.
6. Lee Thuy. The Clinical and Environmental Epidemiology of Penicillium marneffei Infection in Vietnam [Doktora tezi]. Kellogg College Clinical Medicine, 2015.
7. DiSalvo AF, Fickling AM, Ajello L. Infection caused by Penicillium marneffei: description of first natural infection in man. Am J Clin Pathol. 1973:259-63.
8. Sathapatayavongs B, Damrongkitchaiporn S, Saengditha P, Kiatboonsri S, Jayanetra P. Disseminated penicilliosis associated with HIV infection. J Infect. 1989;19:84-5.
9. Supparatpinyo K, Khamwan C, Baosoung V, Nelson KE, Sirisanthana T. Disseminated Penicillium marneffei infection in southeast Asia. Lancet. 1994;344(8915):110-3.
10. Talaromyces (Penicillium) marneffei In: Walsh TJ, Hayden RT, Larone DH(eds.) Larone’s Medically impotant fungi: a quide to identification. 6th eds ASM Press Washington DC
11. Bourassa L, Doppalapudi A, Butler-Wu SM. The Brief Case: Pneumonia Caused by Talaromyces marneffei. J Clin Microbiol. 2019; 57:e01690-18.
12. Centers for Diseases Control and Prevention Talaromycosis (Formerly Penicilliosis) [(accessed on 18 December 2023)];Available online: https://www.cdc.gov/fungal/diseases/other/talarom-
ycosis.html
13. Zaongo SD, Zhang F, Chen Y. An Overview of Diagnostic and Management Strategies for Talaromycosis, an Underrated Disease. J Fungi (Basel). 2023 ;9:647.
14. Thompson GR 3rd, Le T, Chindamporn A et al. Global guideline for the diagnosis and management of the endemic mycoses: an initiative of the European Confederation of Medical Mycology
in cooperation with the International Society for Human and Animal Mycology. Lancet Infect Dis. 2021;21(12):e364-e374.
15. Kurt AF, Cicek E, Alhelou TAM, Mete B, Karaali R, Kuskucu MA, Yazgan Z, Yasar Arsu H, Yıldız Kaya S, Aygun G, Tabak F. Talaromyces marneffei infection in an HIV infected patient with
hematological malignancy – first report from Turkey. New Microbiol. 2023; 46:311-314.
16. Zeng, Q., Jin, Y., Yin, G. et al. Peripheral immune profile of children with Talaromyces marneffei infections: a retrospective analysis of 21 cases. BMC Infect Dis 21, 287 (2021).
17. Spallone A, Schwartz IS. Emerging Fungal Infections. Infect Dis Clin North Am. 2021;35:261-277.
18. Deng Z, Ribas JL, Gibson DW, Connor DH. Infections caused by Penicillium marneffei in China and Southeast Asia: review of eighteen published cases and report of four more Chinese cases.
Rev Infect Dis. 1988 ;10:640-52.
19. https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/talaromycosis?view=full
20. Limper AH, Adenis A, Le T, Harrison TS. Fungal infections in HIV/AIDS. Lancet Infect Dis. 2017 ;17:e334-e343.
21. Cao C, Xi L, Chaturvedi V. Talaromycosis (Penicilliosis) Due to Talaromyces (Penicillium) marneffei: Insights into the Clinical Trends of a Major Fungal Disease 60 Years After the Discovery
of the Pathogen. Mycopathologia. 2019 ;184:709-720.
22. Narayanasamy S, Dat VQ, Thanh NT et al., A global call for talaromycosis to be recognised as a neglected tropical disease. Lancet Glob Health. 2021 ;9:e1618-e1622.
23. Valero C, Martín-Gómez MT, Buitrago MJ. Molecular Diagnosis of Endemic Mycoses. J Fungi (Basel). 2022;9:59.
24. Özhak B, Talaromyces marneffei İnfeksiyonu. In: Tümbay E, ed. Tıbbi Mikoloji. 1. Baskı. İzmir: Meta Basım; 2021.